Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallach

Showing results (341-350 of 457) with videos related to

Pageof 46
Sort By:
The Journal of Experimental Medicine|August 1, 1994
Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicityJ Bigda, I Beletsky, C Brakebusch, et al.
Clinical and Experimental Immunology|September 1, 1993
Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytesA Kalinkovich, G Livshits, H Engelmann, et al.
JAMA|December 11, 2023
Pivotal Trial Demographic Representation and Clinical Development Times for Oncology TherapeuticsAlissa K Wong, Jennifer E Miller, Maryam Mooghali, et al.
The Journal of Biological Chemistry|August 8, 1997
CASH, a novel caspase homologue with death effector domainsY V Goltsev, A V Kovalenko, E Arnold, et al.
JAMA Health Forum|August 17, 2022
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017Joshua J Skydel, Alexander C Egilman, Joshua D Wallach, et al.
Plos Biology|January 5, 2016
Reproducible Research Practices and Transparency across the Biomedical LiteratureShareen A Iqbal, Joshua D Wallach, Muin J Khoury, et al.
BMJ (Clinical Research Ed.)|October 5, 2022
Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional studyMeera M Dhodapkar, Xiaoting Shi, Reshma Ramachandran, et al.
The EMBO Journal|October 1, 1990
Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptorY Nophar, O Kemper, C Brakebusch, et al.
Journal of the American Academy of Dermatology|June 1, 1986
Fibroblastic rheumatismM D Vignon-Pennamen, B Naveau, C Foldes, et al.
Clinical and Experimental Immunology|September 1, 1992
Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infectionA Kalinkovich, H Engelmann, N Harpaz, et al.
Pageof 46

Showing results (341-350 of 457) with videos related to

Sort By:
Pageof 46
The Journal of Experimental Medicine|August 1, 1994
Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicityJ Bigda, I Beletsky, C Brakebusch, et al.
Clinical and Experimental Immunology|September 1, 1993
Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytesA Kalinkovich, G Livshits, H Engelmann, et al.
JAMA|December 11, 2023
Pivotal Trial Demographic Representation and Clinical Development Times for Oncology TherapeuticsAlissa K Wong, Jennifer E Miller, Maryam Mooghali, et al.
The Journal of Biological Chemistry|August 8, 1997
CASH, a novel caspase homologue with death effector domainsY V Goltsev, A V Kovalenko, E Arnold, et al.
JAMA Health Forum|August 17, 2022
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017Joshua J Skydel, Alexander C Egilman, Joshua D Wallach, et al.
Plos Biology|January 5, 2016
Reproducible Research Practices and Transparency across the Biomedical LiteratureShareen A Iqbal, Joshua D Wallach, Muin J Khoury, et al.
BMJ (Clinical Research Ed.)|October 5, 2022
Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional studyMeera M Dhodapkar, Xiaoting Shi, Reshma Ramachandran, et al.
The EMBO Journal|October 1, 1990
Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptorY Nophar, O Kemper, C Brakebusch, et al.
Journal of the American Academy of Dermatology|June 1, 1986
Fibroblastic rheumatismM D Vignon-Pennamen, B Naveau, C Foldes, et al.
Clinical and Experimental Immunology|September 1, 1992
Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infectionA Kalinkovich, H Engelmann, N Harpaz, et al.
Pageof 46